{"ticker": {"uuid": "24ce1f2d-c50d-4432-93ce-ed76c52044c9", "symbol": "COPN", "name": "Cosmo N.V.", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Cosmo schedules July 23 results webcast, with CEO and CFO on call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWER3WTlZUm9aRUhOamEwNGhHclBwVG1LZ0hvM29HX2JiOU9jN0I5TVdmV05iNExUZ2lGVzl2VkRXd2toZUdvVXNnd3Mzejk2QnVhQ3RlOXFMYjl1RXhkT2s0ZVBYdDN0elhyc3A3M2RGbFc0b2hYU0NxR1JVWTJHamlKNm16TVJ6VjBOeThYRzZXV2t2NExHb25lZHJVUW1mMUlfQW51VDVkaUxXdVBnbEwyRnlMbkV0WXpSY2pESzNTdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals NV Actuals & Estimates (SIX:COPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNd2F6SHV2YU5hbVV6S0FEOHAtVUN2TXNRem9UODRGTlZQTTlORG5ZV2hGX1AzWkdULVl3QmU5aXpzZGpMUHJtZ1FYOHdXQ3pXUVc1azVpel9HbWpSN0ZOUXFGdmZWYVNNaDJiSktxUTRiNUhmTVBMWEtOYU1uenlDUmRB?oc=5", "source_name": "TradingView", "published_at": "2026-06-27T07:56:42+00:00", "published_display": "27 Jun 2026 07:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Winlevi\u2019s Europe Launch At Cosmo (SWX:COPN) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo N.V. (SWX:COPN) Valuation Check As Winlevi Launch Advances Across Europe", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo N.V.: Target Price Consensus and Analysts Recommendations | COPN | NL0011832936", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5YWUxOZDR3cFZYeEFIdTllNUpINGEteGtOUmZTd3NSUm90UExPY0JjcXRpeWE4elFSb0c5d2FHSzRNTk55dHJlRElERW5ZVXJfeVZOVzN5UGVYUDk2THY5Rms3YTRsMXpqTG10U1dIeGFLLU1tUUxPMHBqMXk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-18T04:23:01+00:00", "published_display": "18 Apr 2026 04:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTXBkMXZSS2ZjN1lvQ3lqaTRHbV9MVExGcGNtc3p2SEdXbi1FSkwtUm1xMnljUi03NExSandaNTFERkNFcHVwVTh0YVp2S05mNVFHNXV6d1pVTGd0LW1vUjZFcHdabEd5UXpGcFU2dnBJb3FOR2RhZ3NDcVBPNGlHNE9JVFFUOEs3UDRvUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Cosmo Pharmaceuticals (SWX:COPN) After The Recent Share Price Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals (SWX:COPN) Swings To Loss And Tests Bullish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals Achieves 104.2M Revenue and 9.5M EBITDA in 2025; Proposes 2.10 Dividend; Establishes 2026 Growth Framework", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxPb1RRWnY1aU1rN3UzeEo5R2NzaFE0RHNpdGVCajhFZlo1TFlyeG01SW5FR090SkVxazQyQkxxUnl5RnAtdUdoMmt4VEc2RDd4dWxFUDRiWGV2UzB5YllPV3VxYmdMaDJPNzRxQmxJS0tsaGI0Y3VvYnhtY3dHNzNFaEJwTVhwYlJKYkR0c25IbXJwejBmbkdlOXhmWGNGY0RtR2VRQk9NVnVraW14VDY5dHZ5WVJIdWxpdUZCdFdmQWdFWC1tRl9CcExXZ0lyWEp0Q1BjZk5sdTdSRnlrSUpXU2dRcnFpaklXNzh4MjhzOW9WMnlVZmtkYjgyNXRxZHZYWmlxOGQ2SDFTWXkwVHdUSmFTU1BLTFhW?oc=5", "source_name": "TradingView", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Multi Year Returns And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQN0JJTWk0SXlsSElBQzRQak5rTU9xWTRXTm0tcDdGWU1kUVZjWHFlQ0JsTnFldlkyWTE5eVp0Y3RaaGlNUDJQdlJoMzJQa0ZsWGZZR3JlTTZqNXlwMzV1ODFtcldnWkljNi14eGltLWNMY3FNZmJNSDh5ckZZUjJnRFRkcDJsalo1MFN4SHBZVQ?oc=5", "source_name": "Market source", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Private companies are Cosmo Pharmaceuticals N.V.'s (VTX:COPN) biggest owners and were rewarded after market cap rose by CHF61m last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals N.V. (VTX:COPN) Stocks Shoot Up 35% But Its P/E Still Looks Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo shares surge over 20% after Breezula Phase III trials hit key goals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPUzNha2I2UE1YQzVRNjkwbHBEWnVvZjZyUV9NV2lNUFpneGRCUFFLRS1vUzZnb1NucXQtYXowYmtpQzZZaG5oOXo5QjFhQjdtOXhwODNlUkVZWU1MOTdhdkNkNl9YOWRTaVpZWm13RXV0dmQtQXh3XzdEQ2hEMm5UMjFFYVl6LWVra0V0SktRRTJMazN1VWpUV0RNR3pPblBUVjQzUDZjWU54MmI5N1FzaXFXRHBZZWlFaHo4dmhPYnlfcl9rbzBQdw?oc=5", "source_name": "Investing.com", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COSMO PHARMACEUTICALS NV stock price at wienerborse.at/en", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPaHdtOXVIS0dmRjJiRlZRVVNnNG1MSE5Ybmo5ZWhfd2h1WFVKSUg2TmRPcnlkZE1KTTlnWDRIamowakg5Wl9FYVZTTTd4NFNKS081Z2hjTWh2cUs4d2dvSE9ka2pmUE4wWlNnczd0U2VDZW9SeWlLeXgya3cwZUxfVEZneUV5SXpnWV9qczlQODdMdw?oc=5", "source_name": "Wiener B\u00f6rse", "published_at": "2024-09-27T15:36:57+00:00", "published_display": "27 Sep 2024 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals N.v Stock Price Forecast. Should You Buy COPN.SW?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTFBpUjhhNUtyUzdEMmhMdGwxUUpnaGc0MGd3SUNPSTVmNmROREZkNVJabXhfeEJWX0VaSk1XWTdMVkZmdTRMdktYQnhSc1Y?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-16T12:32:54+00:00", "published_display": "16 Dec 2020 12:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cosmo schedules July 23 results webcast, with CEO and CFO on call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWER3WTlZUm9aRUhOamEwNGhHclBwVG1LZ0hvM29HX2JiOU9jN0I5TVdmV05iNExUZ2lGVzl2VkRXd2toZUdvVXNnd3Mzejk2QnVhQ3RlOXFMYjl1RXhkT2s0ZVBYdDN0elhyc3A3M2RGbFc0b2hYU0NxR1JVWTJHamlKNm16TVJ6VjBOeThYRzZXV2t2NExHb25lZHJVUW1mMUlfQW51VDVkaUxXdVBnbEwyRnlMbkV0WXpSY2pESzNTdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals NV Actuals & Estimates (SIX:COPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNd2F6SHV2YU5hbVV6S0FEOHAtVUN2TXNRem9UODRGTlZQTTlORG5ZV2hGX1AzWkdULVl3QmU5aXpzZGpMUHJtZ1FYOHdXQ3pXUVc1azVpel9HbWpSN0ZOUXFGdmZWYVNNaDJiSktxUTRiNUhmTVBMWEtOYU1uenlDUmRB?oc=5", "source_name": "TradingView", "published_at": "2026-06-27T07:56:42+00:00", "published_display": "27 Jun 2026 07:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Winlevi\u2019s Europe Launch At Cosmo (SWX:COPN) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo N.V. (SWX:COPN) Valuation Check As Winlevi Launch Advances Across Europe", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo N.V.: Target Price Consensus and Analysts Recommendations | COPN | NL0011832936", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5YWUxOZDR3cFZYeEFIdTllNUpINGEteGtOUmZTd3NSUm90UExPY0JjcXRpeWE4elFSb0c5d2FHSzRNTk55dHJlRElERW5ZVXJfeVZOVzN5UGVYUDk2THY5Rms3YTRsMXpqTG10U1dIeGFLLU1tUUxPMHBqMXk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-18T04:23:01+00:00", "published_display": "18 Apr 2026 04:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTXBkMXZSS2ZjN1lvQ3lqaTRHbV9MVExGcGNtc3p2SEdXbi1FSkwtUm1xMnljUi03NExSandaNTFERkNFcHVwVTh0YVp2S05mNVFHNXV6d1pVTGd0LW1vUjZFcHdabEd5UXpGcFU2dnBJb3FOR2RhZ3NDcVBPNGlHNE9JVFFUOEs3UDRvUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Cosmo Pharmaceuticals (SWX:COPN) After The Recent Share Price Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals (SWX:COPN) Swings To Loss And Tests Bullish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals Achieves 104.2M Revenue and 9.5M EBITDA in 2025; Proposes 2.10 Dividend; Establishes 2026 Growth Framework", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAJBVV95cUxPb1RRWnY1aU1rN3UzeEo5R2NzaFE0RHNpdGVCajhFZlo1TFlyeG01SW5FR090SkVxazQyQkxxUnl5RnAtdUdoMmt4VEc2RDd4dWxFUDRiWGV2UzB5YllPV3VxYmdMaDJPNzRxQmxJS0tsaGI0Y3VvYnhtY3dHNzNFaEJwTVhwYlJKYkR0c25IbXJwejBmbkdlOXhmWGNGY0RtR2VRQk9NVnVraW14VDY5dHZ5WVJIdWxpdUZCdFdmQWdFWC1tRl9CcExXZ0lyWEp0Q1BjZk5sdTdSRnlrSUpXU2dRcnFpaklXNzh4MjhzOW9WMnlVZmtkYjgyNXRxZHZYWmlxOGQ2SDFTWXkwVHdUSmFTU1BLTFhW?oc=5", "source_name": "TradingView", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Multi Year Returns And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQN0JJTWk0SXlsSElBQzRQak5rTU9xWTRXTm0tcDdGWU1kUVZjWHFlQ0JsTnFldlkyWTE5eVp0Y3RaaGlNUDJQdlJoMzJQa0ZsWGZZR3JlTTZqNXlwMzV1ODFtcldnWkljNi14eGltLWNMY3FNZmJNSDh5ckZZUjJnRFRkcDJsalo1MFN4SHBZVQ?oc=5", "source_name": "Market source", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Private companies are Cosmo Pharmaceuticals N.V.'s (VTX:COPN) biggest owners and were rewarded after market cap rose by CHF61m last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals N.V. (VTX:COPN) Stocks Shoot Up 35% But Its P/E Still Looks Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo shares surge over 20% after Breezula Phase III trials hit key goals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPUzNha2I2UE1YQzVRNjkwbHBEWnVvZjZyUV9NV2lNUFpneGRCUFFLRS1vUzZnb1NucXQtYXowYmtpQzZZaG5oOXo5QjFhQjdtOXhwODNlUkVZWU1MOTdhdkNkNl9YOWRTaVpZWm13RXV0dmQtQXh3XzdEQ2hEMm5UMjFFYVl6LWVra0V0SktRRTJMazN1VWpUV0RNR3pPblBUVjQzUDZjWU54MmI5N1FzaXFXRHBZZWlFaHo4dmhPYnlfcl9rbzBQdw?oc=5", "source_name": "Investing.com", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COSMO PHARMACEUTICALS NV stock price at wienerborse.at/en", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPaHdtOXVIS0dmRjJiRlZRVVNnNG1MSE5Ybmo5ZWhfd2h1WFVKSUg2TmRPcnlkZE1KTTlnWDRIamowakg5Wl9FYVZTTTd4NFNKS081Z2hjTWh2cUs4d2dvSE9ka2pmUE4wWlNnczd0U2VDZW9SeWlLeXgya3cwZUxfVEZneUV5SXpnWV9qczlQODdMdw?oc=5", "source_name": "Wiener B\u00f6rse", "published_at": "2024-09-27T15:36:57+00:00", "published_display": "27 Sep 2024 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cosmo Pharmaceuticals N.v Stock Price Forecast. Should You Buy COPN.SW?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTFBpUjhhNUtyUzdEMmhMdGwxUUpnaGc0MGd3SUNPSTVmNmROREZkNVJabXhfeEJWX0VaSk1XWTdMVkZmdTRMdktYQnhSc1Y?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-16T12:32:54+00:00", "published_display": "16 Dec 2020 12:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 15, "sentiment_summary": {"positive": 5, "negative": 0, "neutral": 10, "score": 55, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 64.3, "latest_week": "2026-07-10", "one_week_move": -8.8, "four_week_move": -8.0, "twelve_week_move": -32.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.206539, "market_dynamics_buy_signal": false, "relative_strength": -26.014596, "fair_value_gap": 0.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.922, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.8% over one week, -8.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 6}, {"label": "TradingView", "count": 2}, {"label": "Market source", "count": 2}, {"label": "Stock Titan", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Wiener B\u00f6rse", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-8.8% over one week, -8.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Cosmo schedules July 23 results webcast, with CEO and CFO on call"}], "updated_at": "2026-07-16T19:16:43.350109+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}